184 related articles for article (PubMed ID: 28843803)
1. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
Kashiwazaki D; Uchino H; Kuroda S
J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
[TBL] [Abstract][Full Text] [Related]
2. Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Maruwaka M; Yoshikawa K; Okamoto S; Araki Y; Sumitomo M; Kawamura A; Yokoyama K; Wakabayashi T
J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):104-11. PubMed ID: 25440344
[TBL] [Abstract][Full Text] [Related]
3. Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease.
Kim SK; Yoo JI; Cho BK; Hong SJ; Kim YK; Moon JA; Kim JH; Chung YN; Wang KC
Stroke; 2003 Dec; 34(12):2835-41. PubMed ID: 14605320
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.
Araki Y; Yoshikawa K; Okamoto S; Sumitomo M; Maruwaka M; Wakabayashi T
BMC Neurol; 2010 Nov; 10():112. PubMed ID: 21059247
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients.
Jin T; Hu LS; Chang M; Wu J; Winblad B; Zhu J
Eur J Neurol; 2007 May; 14(5):563-8. PubMed ID: 17437617
[TBL] [Abstract][Full Text] [Related]
6. Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
Suzuki T; Tozuka M; Kazuyoshi Y; Sugano M; Nakabayashi T; Okumura N; Hidaka H; Katsuyama T; Higuchi K
Ann Clin Lab Sci; 2002; 32(4):369-76. PubMed ID: 12458888
[TBL] [Abstract][Full Text] [Related]
7. Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.
Yokoyama K; Maruwaka M; Yoshikawa K; Araki Y; Okamoto S; Sumitomo M; Kawamura A; Sakamoto Y; Shimizu K; Izumi T; Wakabayashi T
World Neurosurg; 2018 Jan; 109():e446-e459. PubMed ID: 29030229
[TBL] [Abstract][Full Text] [Related]
8. Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics.
Li X; Miyajima M; Mineki R; Taka H; Murayama K; Arai H
Acta Neurochir (Wien); 2006 Aug; 148(8):859-64; discussion 864. PubMed ID: 16755327
[TBL] [Abstract][Full Text] [Related]
9. Association of apolipoprotein E gene polymorphism with small-vessel lesions and stroke type in moyamoya disease: a preliminary study.
Jang DK; Huh PW; Lee KS
J Neurosurg; 2016 Jun; 124(6):1738-45. PubMed ID: 26566210
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis.
Perga S; Giuliano Albo A; Lis K; Minari N; Falvo S; Marnetto F; Caldano M; Reviglione R; Berchialla P; Capobianco MA; Malentacchi M; Corpillo D; Bertolotto A
PLoS One; 2015; 10(6):e0129291. PubMed ID: 26046356
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice.
DeMattos RB; Brendza RP; Heuser JE; Kierson M; Cirrito JR; Fryer J; Sullivan PM; Fagan AM; Han X; Holtzman DM
Neurochem Int; 2001; 39(5-6):415-25. PubMed ID: 11578777
[TBL] [Abstract][Full Text] [Related]
12. Identification of the apolipoprotein E4 isoform in cerebrospinal fluid with preparative two-dimensional electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry.
Hesse C; Nilsson CL; Blennow K; Davidsson P
Electrophoresis; 2001 May; 22(9):1834-7. PubMed ID: 11425239
[TBL] [Abstract][Full Text] [Related]
13. Plasma protein profiling for potential biomarkers in the early diagnosis of Alzheimer's disease.
Kitamura Y; Usami R; Ichihara S; Kida H; Satoh M; Tomimoto H; Murata M; Oikawa S
Neurol Res; 2017 Mar; 39(3):231-238. PubMed ID: 28107809
[TBL] [Abstract][Full Text] [Related]
14. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome.
Yang YR; Liu SL; Qin ZY; Liu FJ; Qin YJ; Bai SM; Chen ZY
Cell Mol Neurobiol; 2008 Aug; 28(5):737-44. PubMed ID: 18343991
[TBL] [Abstract][Full Text] [Related]
15. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
16. 1H-NMR-based metabolomic analysis of cerebrospinal fluid from adult bilateral moyamoya disease: comparison with unilateral moyamoya disease and atherosclerotic stenosis.
Jeon JP; Yun T; Jin X; Cho WS; Son YJ; Bang JS; Kang HS; Oh CW; Kim JE; Park S
Medicine (Baltimore); 2015 May; 94(17):e629. PubMed ID: 25929894
[TBL] [Abstract][Full Text] [Related]
17. A cerebrospinal fluid protein associated with moyamoya disease: report of three cases.
Hojo M; Hoshimaru M; Miyamoto S; Taki W; Kikuchi H; Hashimoto N
Neurosurgery; 1999 Jul; 45(1):170-3; discussion 173-4. PubMed ID: 10414582
[TBL] [Abstract][Full Text] [Related]
18. Proteomic signature of Apolipoprotein J in the early phase of new-onset myocardial infarction.
Cubedo J; Padró T; García-Moll X; Pintó X; Cinca J; Badimon L
J Proteome Res; 2011 Jan; 10(1):211-20. PubMed ID: 21043527
[TBL] [Abstract][Full Text] [Related]
19. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
